Market Research Logo

Global Hemoglobin Testing Market 2016-2020

About the Hemoglobin Testing Market

The red blood cells in the bloodstream carry a protein known as hemoglobin, which helps to transport oxygen throughout the body. Hemoglobin tests are conducted to detect the quantity of hemoglobin present in the blood. These tests are often done as a part of complete blood count during a routine health check-up or at the time of any illness to determine the type of anemia, which occurs due to low count of red blood cells. Studies estimated that worldwide around 416 million people were living with diabetes in 2015. Out of which, around 46% of them, i.e., 191.3 million people, were not diagnosed with this disease, owing to lack of awareness. Diabetes and anemia are not directly linked, but studies reveal that around 26% of people with diabetes are diagnosed with anemia. Kidney damage or chronic kidney disease is a common condition observed in people with chronic diabetes.

Technavio’s analysts forecast the global hemoglobin testing market to grow at a CAGR of 10.58% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global hemoglobin testing market for 2016-2020. To calculate the market size, we use revenue generated from the sales of various types of hemoglobin testing equipment and consumables.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Hemoglobin Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott Diagnostics
  • Alere
  • Danaher
  • EKF Diagnostics Holdings
  • Roche Diagnostics
Other prominent vendors
  • ACON Laboratories
  • ARKRAY
  • Bayer Medical Care
  • Bio-Rad Laboratories
  • Daiichi Biotech
  • DiaSys Diagnostic Systems
  • Diazyme Laboratories
  • Epinex Diagnostics
  • Erba Diagnostics
  • Fisher Scientific
  • GREEN CROSS MEDIS
  • HORIBA
  • HUMAN Gesellschaft für Biochemica und Diagnostica
  • Masimo
  • Mindray Medical International
  • OrSense
  • PTS Diagnostics
  • Randox Laboratories
  • Sebia
  • Siemens Healthcare
  • Sysmex
  • TaiDoc Technology
  • Tosoh Bioscience
  • Trinity Biotech
  • Una Health
Market driver
  • Development and launch of novel hemoglobin testing devices
  • For a full, detailed list, view our report
Market challenge
  • High cost and maintenance of hemoglobin testing
  • For a full, detailed list, view our report
Market trend
  • Direct-to-consumer testing
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Hemoglobin Testing Market 2016-2020

Technavio recognizes the following companies as the key players in the global hemoglobin testing market: Abbott Diagnostics, Alere, Danaher, EKF Diagnostics Holdings, and Roche Diagnostics.

Other Prominent Vendors in the market are: ACON Laboratories, ARKRAY, Bayer Medical Care, Bio-Rad Laboratories, Daiichi Biotech, DiaSys Diagnostic Systems, Diazyme Laboratories, Epinex Diagnostics, Erba Diagnostics, Fisher Scientific, GREEN CROSS MEDIS, HORIBA, HUMAN Gesellschaft für Biochemica und Diagnostica, Masimo, Mindray Medical International, OrSense, PTS Diagnostics, Randox Laboratories, Sebia, Siemens Healthcare, Sysmex, TaiDoc Technology, Tosoh Bioscience, Trinity Biotech, and Una Health.

Commenting on the report, an analyst from Technavio’s team said: “A trend which is boosting market growth is the shift from centralized laboratory use to POCT. The centralized hemoglobin testing methods are useful to diagnose people with diabetes and anemia. However, the time required for the sample analysis is more, and this adds up the time for diagnosis. This drawback of centralized testing has shifted the blood sample analysis to POCT, where the results are provided instantly in the POC settings. This assists physicians in the immediate diagnosis of disease, thereby initiating effective treatment strategies. The POC hemoglobin testing devices are useful, particularly in people with anemia, to check the hemoglobin variants and HbA1c levels.”

According to the report, a key growth driver is the development and launch of novel testing devices by vendors. Development in hemoglobin testing has offered many advantages in the clinical diagnosis methods. Manufacturers develop and launch innovative products in the market, which helps them penetrate the market. For instance, manufacturers are focused on developing hemoglobin test devices that can be used at home settings. In addition, vendors are developing compact and portable devices, which require less space and can be transferred easily during emergency situations.

Further, the report states that one challenge that could hamper market growth is the high cost and maintenance of hemoglobin testing. In the case of POC analyzers it is mandatory to maintain the products with correct functioning to obtain accurate results. Also, storage conditions of blood testing strips and operator's performance need to be checked continuously. The



Companies Mentioned

Abbott Diagnostics, Alere, Danaher, EKF Diagnostics Holdings, Roche Diagnostics, ACON Laboratories, ARKRAY, Bayer Medical Care, Bio-Rad Laboratories, Daiichi Biotech, DiaSys Diagnostic Systems, Diazyme Laboratories, Epinex Diagnostics, Erba Diagnostics, Fisher Scientific, GREEN CROSS MEDIS, HORIBA, HUMAN Gesellschaft für Biochemica und Diagnostica, Masimo, Mindray Medical International, OrSense, PTS Diagnostics, Randox Laboratories, Sebia, Siemens Healthcare, Sysmex, TaiDoc Technology, Tosoh Bioscience, Trinity Biotech, Una Health.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
      • Table Types of hemoglobin testing methods
    • Invasive method
    • Non-invasive method
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global hemoglobin testing market 2015-2020 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by product
    • Table Global hemoglobin testing market segmentation based on product
    • Table Global hemoglobin testing market segmentation based on product 2015
    • Table Global hemoglobin testing market segmentation based on product 2020
    • Global hemoglobin testing equipment market
      • Table Global hemoglobin testing equipment market 2015
      • Table Global hemoglobin testing equipment market 2020
      • Table Global hemoglobin testing equipment market 2015-2020 ($ millions)
      • Table Global laboratory testing market 2015-2020 ($ millions)
      • Table Global POCT equipment market 2015-2020 ($ millions)
    • Global hemoglobin testing reagents and consumables market
      • Table Global hemoglobin testing reagent and consumables market 2015-2020 ($ billions)
      • Table Segmentation of global hemoglobin testing market by product
      • Table Segmentation of global hemoglobin testing market by product ($ millions)
  • Market segmentation by technology
    • Table Segmentation of global hemoglobin testing market by technology 2015
    • Chromatography
    • Immunoassay
    • Other
  • Market segmentation by end-user
    • Table Segmentation of global hemoglobin testing market by end-user 2015
    • Laboratories
    • Hospitals
    • Research centers
  • Geographical segmentation
    • Table Segmentation of global hemoglobin testing market by geography 2015
    • Table Segmentation of global hemoglobin testing market by geography 2020
    • Hemoglobin testing market in Americas
      • Table Hemoglobinin testing market in Americas 2015-2020 ($ millions)
    • Reimbursement by Medicare in US
      • Table Selected laboratory service with national limitation amount (NLA) provided by Medicare
      • Table Estimation of few diseases in US
    • Hemoglobin testing market in EMEA
      • Table Hemoglobin testing market in EMEA 2015-2020 ($ millions)
    • Hemoglobin testing market in APAC
      • Table Hemoglobin testing market in APAC 2015-2020 ($ millions)
      • Table Segmentation of global hemoglobin testing market by geography
      • Table Segmentation of global hemoglobin testing market by geography ($ millions)
  • Market drivers
    • Increasing incidence of diabetes and popularity of HbA1c tests
    • Favorable reimbursement of hemoglobin testing
    • Development and launch of novel hemoglobin testing devices
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • High cost and maintenance of hemoglobin testing
    • Stringent regulatory issues
    • Threat of substitute products
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Shift from centralized laboratory to POCT
    • Increased mergers and acquisition (M&A)
    • Direct-to-consumer testing
  • Vendor landscape
    • Competitive scenario
  • Key vendor profiles
    • Abbott Diagnostics
      • Table Abbott Diagnostics: Key takeaways
    • Alere
      • Table Alere: Business segmentation by revenue 2014
      • Table Alere: Cardiometabolic division revenue and YoY growth rate 2012-2014 ($ millions)
      • Table Alere: Key takeaways
    • Danaher
      • Table Danaher: Key takeaways
    • EKF Diagnostics Holdings
      • Table EKF Diagnostics: Business segmentation by revenue 2014
      • Table EKF Diagnostics: Business segmentation by revenue 2013 and 2014 ($ millions)
      • Table EKF Diagnostics Holdings: Key takeaways
    • Roche Diagnostics
      • Table Roche Diagnostics: Business segmentation by revenue 2015
      • Table Roche Diagnostics: Diabetes care - geographical segmentation by revenue 2015
      • Table Roche Diagnostics: Diabetes care - geographical segmentation by revenue 2014 and 2015 ($ millions)
      • Table Roche Diagnostics: Diabetes care - YoY revenue and growth rate ($ billions)
      • Table Roche Diagnostics: Key takeaways
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report